Coronavirus Update: Lilly Initiates 2,400-Patient Nursing Home Trial

 
• By Scrip Team
  
3D_Coronavirus
LY-CoV555 is a neutralizing antibody against the SARS-CoV-2 spike protein
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from COVID-19

More from Scrip